Business Context and Reporting Period
This Form 8-K, dated October 23, 2024, reports on the special meeting of shareholders held by Glatfelter Corporation. The filing details the approval of a transformative transaction with Berry Global Group, Inc., involving the spinoff of Berry's nonwovens and hygiene films business (HHNF Business) and its merger into a Glatfelter subsidiary. Upon closing, Glatfelter will be renamed Magnera Corporation.
Key Financial Metrics
This filing is a current report regarding corporate governance and transaction approval; it does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data for the reporting period.
Material Changes and Voting Results
Shareholders representing approximately 66.69% of outstanding common stock voted on four proposals. All proposals were approved by a majority of votes cast:
- Proposal 1 (Share Issuance): Approved issuance of shares to Berry's subsidiary (Spinco) for the merger. Votes For: 30,062,308; Votes Against: 227,971.
- Proposal 2A (Charter Amendment - Stock Authorization): Approved increasing authorized common stock from 120,000,000 to 240,000,000 shares. Votes For: 30,034,685; Votes Against: 254,512.
- Proposal 2B (Reverse Stock Split): Approved a reverse stock split at a ratio between 1-for-3 and 1-for-15, to be determined by the Board. Votes For: 30,031,112; Votes Against: 261,703.
- Proposal 3 (Omnibus Plan): Approved the Magnera Corporation 2024 Omnibus Incentive Plan. Votes For: 21,490,348; Votes Against: 8,698,970.
- Proposal 4 (Golden Parachute): Approved, on an advisory basis, executive compensation payments related to the merger. Votes For: 24,574,960; Votes Against: 2,018,691.
Guidance, Outlook, and Risks
The filing includes a cautionary statement regarding forward-looking statements, noting that actual results may differ due to various risks. Key risks identified include:
- Failure to obtain necessary regulatory approvals or delays in obtaining them.
- Termination of the proposed transaction due to unmet closing conditions.
- Unexpected costs, charges, or expenses related to the transaction and separation.
- Integration difficulties and disruption of management time.
- Uncertainty regarding the timing of consummation and potential litigation.
Management does not undertake an obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the final closing date of the transaction and the official renaming to Magnera Corporation.
- Confirm the specific reverse stock split ratio selected by the Board within the approved 1-for-3 to 1-for-15 range.
- Review the definitive Proxy Statement/Prospectus for detailed terms of the merger and the new capital structure.
- Monitor regulatory approval status and any potential conditions imposed by authorities.
- Check for any subsequent filings regarding the implementation of the Magnera Corporation 2024 Omnibus Incentive Plan.